Baseline Characteristics and Survival of Adult Severe Sepsis Patients Treated With Drotrecogin Alfa (Activated) in a Global, Single-Arm, Open-Label Trial (ENHANCE
- 1 January 2003
- Vol. 124 (4) , 91S-c-92S
- https://doi.org/10.1378/chest.124.4_meetingabstracts.91s-c
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: